These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 16421055

  • 1. Faecal calprotectin in children with chronic gastrointestinal symptoms.
    Bremner A, Roked S, Robinson R, Phillips I, Beattie M.
    Acta Paediatr; 2005 Dec; 94(12):1855-8. PubMed ID: 16421055
    [Abstract] [Full Text] [Related]

  • 2. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 3. Use of faecal immunochemical testing as an alternative to faecal calprotectin in children.
    Sandhu K, Naik S, Ayling RM.
    Ann Clin Biochem; 2021 May; 58(3):230-235. PubMed ID: 33412889
    [Abstract] [Full Text] [Related]

  • 4. Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.
    Lozoya Angulo ME, de Las Heras Gómez I, Martinez Villanueva M, Noguera Velasco JA, Avilés Plaza F.
    Gastroenterol Hepatol; 2017 Mar; 40(3):125-131. PubMed ID: 27260632
    [Abstract] [Full Text] [Related]

  • 5. Role of faecal calprotectin as non-invasive marker of intestinal inflammation.
    Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, Sterpi C, Marchi S, Maltinti G.
    Dig Liver Dis; 2003 Sep; 35(9):642-7. PubMed ID: 14563186
    [Abstract] [Full Text] [Related]

  • 6. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM, Nisihara RM, Marion SB, Cavassani MF, Kotze PG.
    Arq Gastroenterol; 2015 Sep; 52(1):50-4. PubMed ID: 26017083
    [Abstract] [Full Text] [Related]

  • 7. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
    Buisson A, Vazeille E, Minet-Quinard R, Goutte M, Bouvier D, Goutorbe F, Pereira B, Barnich N, Bommelaer G.
    Aliment Pharmacol Ther; 2016 May; 43(10):1069-79. PubMed ID: 26953251
    [Abstract] [Full Text] [Related]

  • 8. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP, McNicholl AG.
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [Abstract] [Full Text] [Related]

  • 9. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L, Marzo M, Andrisani G, Felice C, Pugliese D, Mocci G, Nardone O, De Vitis I, Papa A, Rapaccini G, Forni F, Armuzzi A.
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice.
    Berni Canani R, Rapacciuolo L, Romano MT, Tanturri de Horatio L, Terrin G, Manguso F, Cirillo P, Paparo F, Troncone R.
    Dig Liver Dis; 2004 Jul; 36(7):467-70. PubMed ID: 15285526
    [Abstract] [Full Text] [Related]

  • 11. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
    Oyaert M, Trouvé C, Baert F, De Smet D, Langlois M, Vanpoucke H.
    Clin Chem Lab Med; 2014 Mar; 52(3):391-7. PubMed ID: 24114912
    [Abstract] [Full Text] [Related]

  • 12. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
    Diederen K, Hoekman DR, Hummel TZ, de Meij TG, Koot BG, Tabbers MM, Vlieger AM, Kindermann A, Benninga MA.
    Aliment Pharmacol Ther; 2016 Jul; 44(2):181-8. PubMed ID: 27110920
    [Abstract] [Full Text] [Related]

  • 13. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children.
    Olafsdottir E, Aksnes L, Fluge G, Berstad A.
    Acta Paediatr; 2002 Jul; 91(1):45-50. PubMed ID: 11883817
    [Abstract] [Full Text] [Related]

  • 14. What is the faecal calprotectin test?
    Drug Ther Bull; 2014 Sep; 52(9):102-4. PubMed ID: 25213590
    [Abstract] [Full Text] [Related]

  • 15. Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease.
    D'Incà R, Dal Pont E, Di Leo V, Ferronato A, Fries W, Vettorato MG, Martines D, Sturniolo GC.
    Int J Colorectal Dis; 2007 Apr; 22(4):429-37. PubMed ID: 16838143
    [Abstract] [Full Text] [Related]

  • 16. How to use faecal calprotectin in management of paediatric inflammatory bowel disease.
    Saha A, Tighe MP, Batra A.
    Arch Dis Child Educ Pract Ed; 2016 Jun; 101(3):124-8. PubMed ID: 26848103
    [Abstract] [Full Text] [Related]

  • 17. Faecal calprotectin: a marker of inflammation throughout the intestinal tract.
    Summerton CB, Longlands MG, Wiener K, Shreeve DR.
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):841-5. PubMed ID: 12172403
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology.
    Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):615-21. PubMed ID: 15352909
    [Abstract] [Full Text] [Related]

  • 19. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D.
    Gut; 2007 Dec 15; 56(12):1706-13. PubMed ID: 17675327
    [Abstract] [Full Text] [Related]

  • 20. Determination of faecal calprotectin, a novel marker of organic gastrointestinal disorders.
    Røseth AG.
    Dig Liver Dis; 2003 Sep 15; 35(9):607-9. PubMed ID: 14563180
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.